• About
  • Board
  • Expert Index
  • Podcasts
  • News
  • Sign up
  • Contact

Visit

VJHemOnc - Hematological Oncology
  • Home
  • Diseases
    Leukemia
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    Myelodysplastic Syndromes
    Others
    View all Diseases
  • Trials
    • MUK Nine b
    • TEAMM
    • MUK Seven
    • PERSPECTIVE
    • Hokusai VTE-Cancer Study
    • ZUMA-3
    • UKALL14
    • MEDI4736
    • BMS-936558
    • BRIGHT AML1019
    • View all trials
  • Medicines
    • Levofloxacin
    • Edoxaban
    • AMG 330
    • Glasdegib
    • IMGN779
    • Avapritinib
    • Cirmtuzumab
    • Pegfilgrastim
    • Procarbazine
    • Filanesib
    • View all medicines
  • Topics
    • Disease Biology
    • Pharmacy
    • Surgery
    • Treatment
    • Communication
    • Perspectives
    • Policy
    • Psycho-Oncology
    • Supportive Care
    • Transplantation
    • View all topics
  • Conferences
    • HOPA 2018
    • EBMT 2018
    • iwAL 2018
    • UKONS 2017
    • ASH 2017
    • MPN Advances Day 2017
    • NCRI 2017
    • ESH 2017
    • Myeloma 2017
    • BOPA 2017
    • View upcoming conferences
    • View previous conferences
  • Features
    • About
    • Board
    • Expert Index
    • Podcasts
    • News
    • Sign up
    • Contact
T-cell lymphoma: autologous or allogeneic transplant?
Francine Foss
2:27
What are the challenges of integrating therapy around autologous transplantation?
John Kuruvilla
1:03
What is induction therapy for autologous stem cell transplanation?
Michele Cavo
4:59
Conflicting results of the EMN02 and staMINA trials
Michele Cavo
2:50
Current standard of care for patients who are eligible for autologous stem cell transplantation
Michele Cavo
1:57
Promising new combinations in the treatment of myeloma
Evangelos Terpos
1:48
Managing problems in treating CLL
Anna Schuh
1:18
Treatment options for leukemia patients who fail the standard of care
Paolo Ghia
1:13
Have novel drugs made stem cell transplantation obsolete?
David Maloney
3:51
Celebrating 60 years of successful allogeneic transplant at EHA 2017
Mohamad Mohty
5:22
Lymphoid Highlights from BSH 2017
George Follows
2:27
Indications for the use of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma
Anna Sureda
3:31
Advances in multiple myeloma treatment over the last years
Vincent Rajkumar
16:48
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
1:17
What types of post-transplant complications does the biobank project aim to improve?
Regis Peffault de Latour
1:38
Bettering the outcomes of transplant with the French biobank project
Regis Peffault de Latour
  • 1
  • 2
  • 3
  • 4
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
  • Multiple Myeloma
  • B-Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Chronic Myeloid Leukemia
  • Amyloidosis
  • Hodgkin Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Terms of Use
  • Terms of Use
  • Privacy Policy